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Cancer evolution is predominantly studied by focusing on differ-
ences in the genetic characteristics of malignant cells within tu-
mors. However, the spatiotemporal dynamics of clonal outgrowth
that underlie evolutionary trajectories remain largely unresolved.
Here, we sought to unravel the clonal dynamics of colorectal
cancer (CRC) expansion in space and time by using a color-based
clonal tracing method. This method involves lentiviral red-green-
blue (RGB) marking of cell populations, which enabled us to track
individual cells and their clonal outgrowth during tumor initiation
and growth in a xenograft model. We found that clonal expansion
largely depends on the location of a clone, as small clones reside
in the center and large clones mostly drive tumor growth at
the border. These dynamics are recapitulated in a computational
model, which confirms that the clone position within a tumor
rather than cell-intrinsic features, is crucial for clonal outgrowth.
We also found that no significant clonal loss occurs during tumor
growth and clonal dispersal is limited in most models. Our results
imply that, in addition to molecular features of clones such as
(epi-)genetic differences between cells, clone location and the
geometry of tumor growth are crucial for clonal expansion. Our
findings suggest that eithermicro-environmental signals on the tu-
mor border or differences in physical properties within the tumor,
aremajor contributors to explain heterogeneous clonal expansion.
Thus, this study provides further insights into the dynamics of solid
tumor growth and progression, as well as the origins of tumor cell
heterogeneity in a relevant model system.
Colorectal Cancer j Tumor growth j Heterogeneity j Cancer evolution
j Cancer Stem Cells
Introduction
Solid malignancies result from the accumulation of genetic aber-
rations that provide cells with a clonogenic advantage over their
environment, for example by promoting proliferation or reduc-
ing cell death(1-3). However, our incomplete knowledge of the
quantitative effects of these oncogenic events, and the funda-
mental dynamics of tumor expansion, have so far precluded a
thorough understanding of the dynamics of tumor evolution. For
example, it remains unresolved what the effective population
size is that drives long-term tumor expansion and progression(4,
5). Do rare cancer stem cells exist, or are all cells capable of
driving tumor growth? In addition, the impact of the geome-
try of tumor expansion on clonogenic outgrowth is a topic of
great relevance(6). In contrast to hematological malignancies,
cells in solid cancers directly compete for space and nutrients.
Furthermore, the dynamics of tissue turnover and the geometry of
competing clones are predicted to directly impact on evolutionary
trajectories(7, 8). Intra-tumor heterogeneity, which contributes to
resistance to therapies and poor outcome, is a direct consequence
of the concepts introduced above and a better understanding of
these is essential to improve patient outcomes(9, 10). Recently, it
was suggested in the big-bang model of colorectal cancer (CRC)
evolution that spatial separation of competing clones results in a
largely neutral competition, and that the variation in clone sizes
within cancers reflects the age of the clone rather than the relative
clonogenic advantage of the unique molecular properties of that
lineage(11). Yet, this model did not consider the possible het-
erogeneity in clone sizes that could result from a heterogeneous
clonogenicity instilled by the specific geometry of the tumor tissue
and its microenvironment.
Here we set out to investigate the impact of the environment
n clo e size variation in primary xenograft models of human
CRC. We employed the lentiviral gene ontology (LeGO) method
to spatially trace clone lineages within tumors by their unique
red-green-blue (RGB) color-coding(12). This improves on pre-
vious barcoding studies from which spatial information is ab-
sent(13, 14). We found that injection of homogenous populations
of cancer cells results in extensive heterogeneity in clonogenic
outgrowth with large clones located close to the tumor surface.
Our results are in line with two recent studies that suggested
that clonal outgrowth predominantly occurs at the tumor leading
edge and that cell external rather than intrinsic properties deter-
mine the clonogenic potential(7, 8). We expand on our previous
work that utilized short-term lineage tracing only, to study and
explain the complete growth dynamics of established tumors(8).
Importantly, using computational simulations in conjunction with
Significance
Colorectal cancer (CRC) is a heterogeneous disease, with sig-
nificant variation in genotype and phenotype within each
individual tumor. This intra-tumor heterogeneity emerges dur-
ing tumor development due to clonal evolution and in part
can explain therapy resistance in CRC. However, a detailed
understanding of the spatiotemporal development of tumors
underlying cancer evolution and intra-tumor heterogeneity
remains absent. Here, we use lineage-tracing experiments of
human CRC cells transplanted into immunocompromised mice,
in combination with computational modeling, to study the
growth mode of CRC. We found that the clonal position is
crucial for clonal outgrowth. This demonstrates that, in ad-
dition to the genetic composition, the environment and the
geometry of tumor growth play a significant role in shaping
tumor evolution.
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Fig. 1. Clonal tracing by employing the LeGO vector set(A) Schematic
overview of the LeGO system, which includes three vectors containing a con-
stitutively active promotor. Each vector encodes for a different fluorescent
protein, from top to bottom: Cerulean (blue), Venus (green) and mCherry
(red). (B) Theoretical model of the LeGO system whereby mixing of the
three basic colors red, blue and green leads to the generation of the whole
spectrum of rainbow colors. (C) Transduction of cells with the LeGO system
facilitates clonal tracking by marking each cell with a different color. Two
main factors underlie the different color expressions per cell; vector copy
number and stochastic expression depending on the vector insertion site in
the genome.(D) Representative images of LeGO-transduced colon cancer cell
cultures with three different vectors. From left to right; human primary cell
lines Co100, Co147, CC09 and serum-cultured cell line HT55. Scale bars, 100
µM.
detailed clone size measurements, we conclude that the full clone
size heterogeneity is defined by cell-extrinsic features, and thus
no evidence of an intrinsic hierarchy was found in established
CRC tissue. Additionally, we found that clonal dispersal is limited
and that the number of clones remains constant during tumor
growth. Taken together, these findings provide critical insights
in the commonly employed subcutaneous xenograft assay and
indicate that spatial location and time of emergence of a clone is
an important but until nowunder recognized force in colon cancer
evolution and heterogeneity.
Results
Multicolor clonal tracing in colorectal cancer. In order to study
the clonal dynamics that drive expansion of CRC tissue in situ,
we transduced a series of three primary colon cancer cultures
(Co100, Co147 and CC09) and one serum-cultured cell line
(HT55) with the LeGO vector set (Fig. 1A-C). Following titration
of the virus we obtained RGB (red, green, blue) marked cultures
in which cells were labeled with a wide range of unique colors that
allows for clonal tracking (Fig. 1D). Importantly, by monitoring
a series (n=10) of single cell clones by fluorescence-activated
cell sorting (FACS) in time, we confirmed the stability of the
expression of the LeGO vectors and resulting color, as well as the
overall neutrality of the integration events (SI Appendix, Fig. S1).
Next, we injected the cultures using different injection volumes
ofMatrigel subcutaneously in immunocompromised (nude) mice.
We found that the injection volume had an important impact on
the resulting clone configuration. Larger injection volumes (100
µl) resulted in diffuse clonal expansion within the Matrigel plug,
and clones simply expanded until they made contact rather than
being in direct competition early after injection (SI Appendix,
Fig. S2A). Therefore, to resemble clonal growth dynamics of
established colon cancer in our xenograft model, we selected the
smallest injection volume (50 µl) for the follow-up experiments.
Fig. 2. Clonal tracing in colorectal xenografts by LeGO(A) Tumors derived
from injected LeGO-transduced colon cancer cultures are shown. Clockwise;
Co100, CC09, Co147 and HT55. Scale bar, 200 µM.(B) Representative images
of different clones in a LeGO-transduced Co100 tumor containing one or
multiple clones intermingled. The top panel shows monoclonal clones and
the bottom panel shows respectively from left to right a mixture of two and
three clones. Scale bars, 200 µM.(C) Bar graph depicting the percentage of
clones that is monoclonal or a mixture of two or three clones within a tumor
derived from the indicated cell lines as observed in 2D sections. Error bars
represent s.e.m., a minimum of n=5 tumors were analyzed per line.
Analysis of small xenografts of 300 mm3 showed a clear
demarcation of individual clones in all evaluated models (Fig.
2A). We define a clone as a region of identical color representing
the offspring of an individual injected cell. Although multiple
clones can represent with similar colors, we estimate we can
visually separate 96 hues, and combining the RGB marking
with spatial information allows for robust identification of clones
originating from the moment of injection. The various tumor
models presented distinct morphologies. Whereas Co100 and
HT55 xenografts showed a well-differentiated morphology with
evident glandular structures separated by murine stroma, Co147
and CC09 instead were moderate-/poorly differentiated present-
ing with large tissue regions without glandular differentiation
(Fig. 2A). In all models, clonal dispersal was limited, and only
rarely were regions with a mixture of multiple clones in 2D
sections detected (Fig. 2B and 2C). While the fraction of mixed
clones is probably higher if all three dimensions are considered,
it indicates that competition between clones in CRC is mostly
the result of parallel expansion at distinct rates rather than the
result of direct competition within glandular structures, some-
thing that remained elusive before. Also, the limited spread of
clonally related cells throughout larger cancers revealed that the
motility of cancer cells within xenografts is rather limited. These
findings are in line with the results of multi-region sequencing
analysis that indicate that private mutations are often detected
in separate tumor regions and show that the LeGO xenografts
are appropriate model systems to study colon cancer growth and
progression(11, 15, 16).
Effective population size of colorectal cancers. Previous work
has revealed that not all CRC cells have an equal ability to initiate
tumor growth in immunocompromised mice. It has been estab-
lished that cells that express markers of immature cell types such
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Fig. 3. Clone numbers are stable during tumor growth(A) Schematic model of the experimental set-up for clonal outgrowth quantifications per LeGO-
transduced colon cancer cell line. A fixed cell number was injected subcutaneously for each cell line and tumors were isolated at different tumor volumes.
(B) Graph showing the TIC frequency of Co100-, Co147-, CC09- and HT55-derived tumors. Each dot represents one tumor (a minimum of n=8 per cell line),
error bars represent s.e.m.(C) Graph showing the correlation between the average TIC frequency in an in vitro limiting dilution assay versus in vivo LeGO
experiments for the indicated cell lines. R2=0.7358, P value=0.1422, Pearson correlation. Error bars represent s.e.m.(D) Bar graph showing the TIC frequency
ofCo100-, Co147-, CC09- and HT55-derived tumors for two subgroups; tumors indicated as small having an average volume of 170 mm3 and tumors indicated
as big having an average volume of 525 mm3. Error bars represent s.e.m., ns, not significant, Student’s t-test.(E) Graph showing the number of clones as
determined by image analysis for Co147 and HT55 xenografts (minimum of n=3 tumors per injected cell number for each cell line) that were derived from
injections with different cell numbers, error bar represents s.e.m..
as AC133, or that present with high Wnt pathway activity, have
a superior capacity to induce colon cancer xenografts(17-19).
These studies have mostly been performed using limiting dilution
assays, in which a decreasing number of cells is injected, which
then allows for the calculation of the proportion of cells within
a population capable of initiating xenograft growth. However, it
remains unclear how the reduced cell numbers impact on the
ability to initiate tumors, for example due to the lack of para-
and juxtacrine signaling input. Using our model system, we now
have the ability to directly determine the proportion of injected
cells that contributes to tumor initiation using an equal number
of injected cells (Fig. 3A). By high-resolution analysis of xenograft
tissue, and quantification of the number of clones, we could esti-
mate the number of injected cells that actively grew out.We found
that in vivo dispersal of cells is limited (Fig. 2), and this allowed
us to identify each clone that resulted from the expansion of an
injected cell as a connected region of cells with the same color.
We found that the percentage of injected cells contributing to
tumor initiation ranged between2-20%. The highest proportion
of tumor initiating cells (TICs) was detected in the serum cultured
cell line (HT55), and the primary cell cultures displayed more
limited clonogenic potential during the initiation phase (Fig. 3B).
Additionally, comparison of the TIC frequency in the LeGO
model versus the in vitro limiting dilution assay revealed only
a weak correlation between both methods for determining the
clonogenicity of tumor cells (Fig. 3C). We found that the limiting
dilution assay could both under- and overestimate the clonogenic
cell frequency. This indicates that in some models, injection of a
larger cell number suppresses outgrowth of cells, as for example
in Co147, while in another model the co-injected cancer cells
promote outgrowth of cells (e.g. Co100). Hence, we suggest that
the interpretation of data derived from an in vitro assay about the
clonogenic capacity of tumor cells should be done with caution.
Importantly, the estimated proportion of cells initiating tumor
growth was independent of the tumor volume analyzed (Fig. 3D)
and actual number of cells injected (Fig. 3E), indicating that
clones that contribute to tumor initiation permanently reside in
the tumor tissue, and are not lost due to competition for example,
making this assay robust to analyze different time points or tumor
volumes.
Growth dynamics of colorectal cancer tissue.To elucidate the
underlying dynamics of colon cancer tissue expansion we mixed
LeGO cultures with non-transduced cultures. This had the bene-
fit that LeGO clones were better separated and allowed us to use
a semi-automated image analysis pipeline to quantify the clone
sizes within the whole xenograft tissues (Fig. 4A andMaterial and
Methods). Analysis of hundreds of clones within tumors of differ-
ent sizes revealed that on average themedian clone size increased
as expected in an expanding tissue (Fig. 4B). More interestingly,
we detected that the heterogeneity in clone sizes was very large,
and many clones remained small and did not seem to significantly
contribute to tumor expansion (Fig. 4B and SI Appendix, Fig. S3).
When plotting the relation between the proportion of clones that
contribute to which fraction of tumor volume, we indeed detected
that a small number of clones is responsible for the majority of
the tumor growth (Fig. 4C). Furthermore, in larger tumors, the
trend towards a relatively small number of clones driving tumor
expansion is increased (Fig. 4C). It has been observed previously,
by using genetic clonal tracing strategies in solid tumors, that not
all cells contribute equally to cancer growth. In those studies,
this heterogeneity was attributed to the intrinsic differences in
clonogenic potential of cells, resulting from different cell states,
i.e. stem cells vs. differentiated cells(13, 14). We now have the
ability to evaluate this by studying the configuration of clones
within the tissue. As is immediately apparent from the images
from whole LeGO xenograft sections, there is a clear relation-
ship between the position of the clone and its size in all cancer
models studied (Fig. 4A and D, SI appendix, Fig. S2A-D). Larger
clones are predominantly located at the xenograft edges, implying
that competition for an optimal location instead of the intrinsic
properties of clones defines which clones drive expansion in this
model. This implies that before clones get into direct competition,
i.e. before an established tumor has formed from the injected
cells, the heterogeneity in clone sizes is much smaller. Indeed,
in very small tumors, where clones are not yet in contact, all
clones appear to expand equally (SI Appendix, Fig. S2A). These
results are in line with two recent studies that used short-term
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Fig. 4. Clones located on the tumor edge contribute most to tumor
growth(A) Representative cross sectional image of xenograft showing a large
variety of clone sizes, with larger clones towards the xenograft edge. Scale
bar, 1 mm. (B) Clone sizes per tumor ordered by tumor size. Individual
clones (dots) and median clone size per tumor (line). Inset show median
clone sizes.(C) Cumulative clone size as a fraction of the total cross sectional
area per tumor. The red dashed line displays the theoretical curve for
a homogeneous distribution of sizes among clones.(D) Clone size versus
distance to edge. Sizes and distances are normalized to themaximum of each
xenograft. The red line is a polynomial fit to the clone sizes.
lineage-tracing strategies to confirm that clonal proliferation is
most abundant at the leading edge of cancers(7, 8). Addition-
ally, we have generated pancreatic ductal carcinoma (PDAC)
xenografts from LeGO transduced cultures, and confirmed that
PDACs show very similar growth dynamics as the CRC xenografts
(SI appendix, Fig. S4). To test if the leading edge might differ
intrinsically from the center, we first confirmed that our cell lines
contain genetic variations on the copy number level as described
recently for other lines(20, 21). Significant genetic variations
were detected between various xenografted tumors as well as the
parental line (SI Appendix, Fig. S5A). This shows that genetic
diversity is maintained in primary CRC cell cultures employed
here, albeit potentially less as compared to in situ human cancers.
In contrast, we found no significant differences in copy number
between the edge and center of the same tumor (SI Appendix, Fig.
S5B). Therefore, spatial difference in growth does not coincide
with the observed genetic heterogeneity. Moreover, when cells
derived from the center or edge of one tumor are re-transplanted,
no difference in the growth rate was observed (SI Appendix, Fig.
S5C) confirming that larger clones residing at the tumor edge are
not intrinsically fitter.
Modeling colorectal cancer growth. To further support the
notion that locations of founding cells rather than cell intrinsic
features determine the in vivo clonogenic potential, we developed
a cellular automaton model to simulate xenograft expansion with
growth either confined to the surface or throughout the whole
tumor (Fig. 5A and SI Appendix, Movies S1-3). If neither of the
models (volume or surface growth) could explain the data, this
would argue in favor of intrinsic differences between cells, for
example as proposed by the cancer stem cell theory. We model
tumor growth in 3D as a population of cells that stochastically
replicate when they have sufficient free space available for the
offspring (SI Appendix, Computermodels), similar to our previous
work(6) . In the surface growth model, cells replicate only on
the surface. In the volume growth model, as the tumor expands,
free space is created inside the tumor which causes it to grow
exponentially. The initial tumor conditions are taken tomatch the
xenograft experiments: 10.000 uniquely labeled cells in a volume
of 50 µl. Tumor growth is simulated until the maximum size of
1.3 billion cells, which corresponds to a tumor volume of 1.3 cm3,
which is well above the maximum tumor volume in our xenograft
experiments. For direct comparison with the experimental data
we take virtual 2D sections from the simulated tumors at var-
ious positions and quantify clone sizes (SI Appendix, Computer
models). With growth confined to the surface we found excellent
agreement between the simulated clone sizes as a function of
the overall tumor volume, and the experimentally observed clone
sizes (Fig. 5B).Moreover, the clone size distributions and patterns
from the simulated environment-instructed tumor growth were
highly similar to the clone patterns observed in the xenografts
(Fig. 5C). In contrast, volume growth results in exponentially
growing tumors with a different pattern of clonal expansion that
does not explain the experimental data (Fig. 5C and 5D). The
spatiotemporal localization of growth is therefore crucial to ex-
plain the data and results in a large heterogeneity of clone sizes
even if all clones have an equal growth rate (neutral dynamics). To
assess the effect of non-neutrality we modeled tumor growth with
non-uniform growth rates of clones (normal distributed growth
rates, mean = 1, standard deviation = 0.05, 0.1 or 0.2). We find
that the clone size distribution is very similar to the neutral case
(SI Appendix, Fig. S6A). Other biologically realistic alterations of
the model (a stem cell hierarchy or extensive cell death during
growth) also only induce subtle changes in the growth pattern as
revealed by the distribution of clone sizes (SI Appendix, Fig. S6B).
Together these results indicate that in situ clonogenicity for clones
of equal age is the result of spatial organization of the tissue.
Discussion
Using a color-based clonal tracing method in combination with
primary human CRC cultures, we obtained important insights in
the dynamics of colon cancer xenograft growth and clonal hetero-
geneity. Firstly, we revealed that the initiation phase of xenograft
growth is dependent on the volume used for injection, and the
number of cells injected. Controlling these variables is essential
for accurate interpretation of TIC assays and clonal competition
studies. Secondly, the xenografts fromLeGO-transduced primary
cultures revealed that clonal dispersal and clonal mixing is lim-
ited in colon cancer xenografts. This observation has important
implications, as it strengthens the notion that clones in colon
cancer tissue expand in parallel when residing in an identical
environment. Also, this provides geometrical support to the idea
that a large proportion of CRCs display predominantly neutral
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Fig. 5. Clonal expansion is highly dependent on
clone location(A) Cross sections of tumors of increas-
ing size, simulated with stochastic growth confined
to the surface (top panel) or throughout the entire
tumor (volume growth, bottom panel). Tumor sizes
(in million cells) from left to right for respectively the
top and bottom panel: 50, 100, 300, 600, 900 and 25,
150, 600 and 1400. (B-D) Comparison of experimental
data (black dots) with model predictions of surface
(red lines) and volume growth (dashed blue lines).
evolution and that no large selective sweeps follow emergence of
novel, more aggressive clones in established cancers.
Previous short-term lineage tracing experiments by us and
others indicated that clonal expansion is spatially regulated in
established CRC xenograft tissue(7, 8). In these studies clones
expressing one or a few different colors were induced in estab-
lished tumors. The small number of colors in these experimental
systems prevented long-term tracing of individual clones because
growth and merging of neighboring clones are hard to distinguish
with a limited resolution. In the current study we have overcome
this limitation, which has enabled us to study long-term clonal
dynamics in xenografts of established CRCs. The combination of
long-term lineage tracing and computational modeling revealed
that clone size heterogeneity can be fully explained by externally
driven growth at the leading edge of the tumor. In contrast,
previous barcoding studies in human xenografts indicated that
distinct types of stem-like cells in colon cancer xenografts ex-
hibit distinct repopulating features caused by intrinsic functional
differences in the self-renewal and tumor forming capacity of
tumor cells(13, 14). Our data provide a radically different ex-
planation for these observations by showing that these different
contributions to tumor expansion following xenograft propaga-
tion are spatially orchestrated rather than intrinsically defined.Of
note, studying clonal dynamics of early phases of pre-malignant
expansion and conversion towards CRC falls beyond the scope
of this study, but in these early stages the clonal dynamics are
possibly more defined by genomic differences between clones. In
addition, our model system lacks a functional immune system and
immune-effects are not captured in our study. Notwithstanding,
we conclude that within the time frame and spatial-scale of our
experimental set-up, the tumor environment is a dominant factor
in shaping CRC growth and progression, as expansion mainly
occurs at the tumor edge.
Several factors can explain the observed growth at the tumor
edge. For example, the enrichment for stroma and secretion of
stromal factors can drive clonogenic expansion at the leading
edge. The increased interstitial pressure within the xenograft
centers is also likely to contribute. Importantly, manipulation of
these factors could yield novel therapeutic avenues to improve
treatment, and we are currently following up on this by targeting
Osteopontin(8). Furthermore, targeting the intercellular machin-
ery associated with clonogenic potential, as a cell state enabled by
the environment, is another strategy that could be developed to
improve the prognosis of patients with solid cancers.
Materials and Methods
Cell culture. Human primary colon cancer cultures were established as de-
scribed previously(18). Cultures were isolated from patients with colorectal
cancer with approval of the medical ethical committee of the AMC and
University of Palermo. Primary cell lines are cultured in polyHEMA (Poly(2-
hydroxyethyl methacrylate, Sigma) coated flasks (Corning) to allow spheroid
growth. Advanced DMEM/F12 (Life Technologies), culture medium is used
which is supplemented with N-2 (Life Technologies), L-glutamine, glucose,
HEPES, heparin, insulin, epidermal growth factor (EGF) and basic fibroblast
growth factor (bFGF) as described previously(18). The primary human PDAC
culture 067 was established as described previously(22) and cultured in
IMDM (Life Technologies) supplementedwith 8% FBS and L‐glutamine. DLD1
(ATCC) and HT55 (Sanger institute, UK) cells were cultured in DMEM/F12
(Life Technologies) supplemented with 8% FCS (Life Technologies). Capan-2
(ATCC) was cultured in DMEM (Life Technologies) supplemented with 8%
FCS. Cell lines were authenticated by STR profiling in combination with
mutation analysis and have been regularly tested for mycoplasma infection.
Multicolor marking. Cell lines were simultaneously transduced with
three different constructs according to a previously published protocol(12).
The following lentiviral gene ontology (LeGO) vectors were used; LeGO-C2
(27339), LeGO-V2 (27340) and LeGO-Cer2 (27338) (Addgene). In short, 50,000
single cells were seeded in a 24-well plate in 500 µl culture medium in the
presence of 8 μg ml−1 polybrene (Sigma). Lentivirus containing the three
vectors was added in a volume that ensured60% transduction rate of each
vector. Plates were centrifuged for 1 hour at 24°C and incubated overnight
at 37°C. Transduction rates were analyzed by flow cytometry after three
days. After transduction, cell lines were passaged in a low dilution and for a
maximum of five passages before in vivo use.
Flow Cytometry. Flow cytometry was performed on a Fluorescence
Activated Cell Sorting (FACS) Aria SORP (BD Biosciences) machine with 405-
, 488- and 561-nm lasers. Data was analyzed with the FlowJo (FlowJo LLC)
software.
Vector expression. Vector integration stability was analyzed by FACS.
DLD1 cells were transducedwith the LeGO system and then single-cell sorted.
Single-cell clone cultures were expanded and passaged twice a week. Upon
passaging the expression of Cerulean, Venus and mCherry was analyzed by
FACS. Every cell line was analyzed at least twice in a 12-week follow-up
period.
In vivo experiments. The Animal Experimentation Committee at the
AcademicMedical Center in Amsterdam has approved all in vivo experiments
(DEC103181) and all animal experiments were performed according to the
national guidelines. Female nude (Hsd:Athymic Nude-Foxn1nu) mice (6-12
weeks old) were obtained from Envigo. Animals were randomly assigned to
experimental groups, no blinding was applied for these experiments. Animal
exclusion was performed when no tumor growth appeared.
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Xenograft studies. Xenograft tumors were generated by injecting
10,000 (CC09) or 50,000 (Co100, Co147 and HT55) human colon cancer cells
in a mixture of medium and Matrigel (Corning) in a 1:1 ratio with a cell
density of around 400-1.000 cell/µL. Cells were injected subcutaneously into
the flanks of nude mice. Tumor growth was measured manually twice a
week using a caliper. Mice were sacrificed based on tumor size at various
time points to isolate tumors. After isolation tumors were fixed using 4%-
paraformaldehyde in phosphate buffered saline solution overnight at 4°C
followed by preservation in a 20% sucrose solution for ̴12 hours at 4°C.
Tumors were split into two equally sized parts and 10 µm-thick frozen tissue
sections were collected from the tumor center.
In vivo transplantation assay. Center and edge (<0.5 mm from tumor
border) located cells were isolated from freshly collected xenografts by using
razor blades. Immediately after tissue collection, cells were dissociated by
using medium containing collagenase (Roche) and hyaluronidase (Sigma)
at 37°C for 1 hour. Before injection, cells were filtered using a 70 µM cell
strainer and dead cells were removed by 7-AAD staining (BD Biosciences) by
using FACS. For each group, 1,000 cells were injected subcutaneously into the
flanks of nude mice (n=3) and tumor growth was measured twice a week.
Copy number analysis. DNA was extracted using the NucleoSpin Tissue
kit (Bioké) following the manufacturers procedure. To extract DNA from
the in- and outside of tumors, we first mechanically separated the two
regions. Shallow sequencing and data analysis were performed as previously
described(23).
Limiting dilution assay. Cells were dissociated and plated in 96-wells
plates (Corning) using SH800 Cell Sorter (Sony) in a limiting dilution manner
at 1, 2, 4, 8, 16, 24, 32, 64, 128, 256 cells per well. Clonal frequency and
significance were determined using the Extreme Limiting Dilution Analysis
(ELDA) ‘Limdil’ function(24).
Imaging. Frozen tissue sections were imaged by an EVOS FL Cell Imaging
System (Thermo Fisher Scientific). Sections were covered with ProLong Gold
Antifade Mountant (Thermo Fisher Scientific) to ensure fluorescent signal
preservation. Whole tumor sections were scanned for mCherry, Venus and
Cerulean by using the following LED light cubes; TexasRed (excitation 445/45
and emission 510/42 nm), YFP (excitation 500/24 and emission 524/27 nm)
and CFP (excitation 585/29 and emission 624/40 nm). For high-resolution
imaging a SP8-X confocal microscope (Leica) with the Leica Application Suite-
Advanced Fluorescence software was used.
Image analysis. Automated clone size quantification and localization
was performed on whole tumor cross sectional slides imaged by fluorescence
microscopy and converted to .tiff file format with a custom written MATLAB
program. Boundaries of connected regions with the same color and cross
sections, were manually highlighted for accurate tracking of clone position
and size. Connected regions with the same color, but separated by >10 cell
diameters were considered as separate clones. The number of mixed clones
was identified manually.
Spatial model for tumor growth. We adapted the 3D spatial model
we recently introduced for tumor evolution, for direct comparison with
the xenograft data(6). In short, in this model tumor cells occupy sites of
a regular 3D lattice. To simulate growth, iteratively a random cell which
has at least one of the neighboring sites (Von Neumann neighborhood)
vacant, replicates to a randomly chosen vacant neighbor site. A detailed
description of the computational modelling, a description of the different
model versions, and how numerical data is compared to the experimental
data can be found in SI Appendix, Computer models.
Statistical analysis. Sample sizes, statistical tests and definitions of error
bars are indicated in the figure legends and calculated using GraphPad
Prism 7 or MATLAB. All statistical tests were two-sided. The between-group
variances were similar and the data were normally distributed. P values of <
0.05 were considered significant.
Data availability. Source data for Figure 4 and 5 and Figure S3 is provided
in Dataset S1.
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